Evidence map›Paper›PMID 35293849›Full record

ArticleEmerging microbes & infections2022

RT-LAMP assay for rapid detection of the R203M mutation in SARS-CoV-2 Delta variant.

Jianing Yang, Xuejiao Hu, Wenzhuo Wang, Yujing Yang, Xinqiang Zhang, Wei Fang, Lei Zhang, Shan Li, Bing Gu

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jianing YangMOE International Joint Laboratory for Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P.R. China.
Xuejiao HuLaboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou 510000, P.R. China.
Wenzhuo WangMOE International Joint Laboratory for Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P.R. China.
Yujing YangLaboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou 510000, P.R. China.
Xinqiang ZhangLaboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou 510000, P.R. China.
Wei FangLaboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou 510000, P.R. China.
Lei ZhangMOE International Joint Laboratory for Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P.R. China.
Shan LiMOE International Joint Laboratory for Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P.R. China.
Bing GuLaboratory Medicine, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou 510000, P.R. China.
Guangdong Provincial People's Hospital · CNSouth China University of Technology · CNGuangdong Academy of Medical Sciences · CNGuangdong Institute for Drug Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The highly infectious Delta variant strain of SARS-CoV-2 remains globally dominant and undermines COVID-19 vaccines. Rapid detection of the Delta variant is crucial for the identification and quarantine of infected individuals. In this study, our aim was to design and validate a genotyping RT-LAMP method to detect Delta variants specifically. R203M in the

Indexed as

COVID-19SARS-CoV-2COVID-19 VaccinesHumansMolecular Diagnostic TechniquesMutationNucleic Acid Amplification TechniquesSensitivity and SpecificityCOVID-19 VaccinesDelta variantR203M mutationrapid diagnosisRT-LAMPSARS-CoV-2

Identifiers

PMID35293849
PMCPMC8982466
OpenAlexW4220957680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.